KamalNMenghrajaniMD

PubMed

• High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancer.
  Aaron J Stonestrom, Kamal N Menghrajani, Sean M Devlin, Sebastià Franch-Expósito, Ryan N Ptashkin, Swara Y Patel, Barbara Spitzer, Xiaodi Wu, Justin Jee, Pablo Sánchez...> ;Blood Advances. 2024 Feb 27
• Acute Myeloid Leukemia Presenting as Common Colds: An Uncommon Consideration.
  Fusillo, T., Millman, S., Menghrajani, K.> ;Cureus. 2024 Jan 1
• 2 citations
  Associations Between Cancer Predisposition Mutations and Clonal Hematopoiesis in Patients With Solid Tumors.
  Sebastià Franch-Expósito, Miika Mehine, Ryan N Ptashkin, Kelly L Bolton, Chaitanya Bandlamudi, Preethi Srinivasan, Linda Zhang, Margaret A Goodell, Erika Gedvilaite, K...> ;JCO Precision Oncology. 2023 Aug 1
• Oncogenic IDH mutations increase heterochromatin-related replication stress without impacting homologous recombination.
  Juan-Manuel Schvartzman, Grace Forsyth, Henry Walch, Walid Chatila, Angelo Taglialatela, Brian J Lee, Xiaolu Zhu, Steven Gershik, Francesco V Cimino, Anthony Santella,...> ;Molecular Cell. 2023 Jul 6
• 2 citations
  Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia.
  Maximilian Stahl, Andriy Derkach, Noushin Farnoud, Jan Philipp Bewersdorf, Troy Robinson, Christopher Famulare, Christina Cho, Sean Devlin, Kamal Menghrajani, Minal A ...> ;American Journal of Hematology. 2023 Jan 1
• 5 citations
  Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML.
  Kamal Menghrajani, Alexandra Gomez-Arteaga, Rafael Madero-Marroquin, Mei-Jie Zhang, Khalid Bo-Subait, Jonathan Sanchez, Hai-Lin Wang, Mahmoud Aljurf, Amer Assal, Ulrik...> ;Blood Advances. 2021 Sep 22
• 16 citations
  Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant.
  Jan Philipp Bewersdorf, Andriy Derkach, Lohith Gowda, Kamal Menghrajani, Susan DeWolf, Josel D. Ruiz, Doris M. Ponce, Brian C. Shaffer, Roni Tamari, James W. Young, An...> ;Leukemia & Lymphoma. 2021 Sep 3
• 89 citations
  Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML
  Maximilian Stahl, Kamal Menghrajani, Andriy Derkach, Alexander Chan, Wenbin Xiao, Jacob L. Glass, Amber C. King, Anthony F. Daniyan, Christopher Famulare, Bernadette M...> ;Blood Advances. 2021 Mar 9
• 6 citations
  The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy.
  Brian Ball, Meier Hsu, Sean M. Devlin, Maria E. Arcila, Mikhail Roshal, Yanming Zhang, Chris A Famulare, Aaron D Goldberg, Sheng F. Cai, Andrew Dunbar, Zachary D. Epst...> ;American Journal of Hematology. 2021 Mar 1
• 1 citations
  Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.
  Elsa Bernard, Yasuhito Nannya, Robert P Hasserjian, Sean M Devlin, Heinz Tuechler, Juan S Medina-Martinez, Tetsuichi Yoshizato, Yusuke Shiozawa, Ryunosuke Saiki, Luca ...> ;Nature Medicine. 2021 May 1
• 1 citations
  Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.
  Elsa Bernard, Yasuhito Nannya, Robert P Hasserjian, Sean M Devlin, Heinz Tuechler, Juan S Medina-Martinez, Tetsuichi Yoshizato, Yusuke Shiozawa, Ryunosuke Saiki, Luca ...> ;Nature Medicine. 2021 Mar 1
• 53 citations
  Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis
  Teng Gao, Ryan Ptashkin, Kelly L. Bolton, Maria Sirenko, Christopher J. Fong, Barbara Spitzer, Kamal Menghrajani, Juan E. Arango Ossa, Yangyu Zhou, Elsa Bernard, Max L...> ;Nature Communications. 2021 Jan 12
• 6 citations
  Acute myeloid leukemia with 11q23 rearrangements: A study of therapy-related disease and therapeutic outcomes
  Kamal Menghrajani, Yanming Zhang, Christopher Famulare, Sean M. Devlin, Martin S. Tallman> ;Leukemia Research. 2020 Nov 1
• 307 citations
  Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
  Elsa Bernard, Yasuhito Nannya, Robert P. Hasserjian, Sean M. Devlin, Heinz Tuechler, Juan S. Medina-Martinez, Tetsuichi Yoshizato, Yusuke Shiozawa, Ryunosuke Saiki, Lu...> ;Nature Medicine. 2020 Aug 3
• 13 citations
  Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia - results from an international collaborative study.
  Sabine Kayser, Robert Kerrin Hills, Marlise R. Luskin, Andrew M. Brunner, Christine Terré, Jörg Westermann, Kamal Menghrajani, Carole Shaw, Maria R. Baer, Michelle A. ...> ;Haematologica. 2020 Jan 1
• 12 citations
  Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia.
  Wenbin Xiao, Aaron D Goldberg, Christopher Famulare, Sean M. Devlin, Nghia T. Nguyen, Sinnifer Sim, Charlene C. Kabel, Minal Patel, Erin McGovern, Akshar Patel, Jessic...> ;Haematologica. 2019 Jul 1
• 1 citations
  Predictive models for splenic response to JAK-inhibitor therapy in patients with myelofibrosis.
  Kamal Menghrajani, Philip S. Boonstra, Jessica Mercer, Cecelia Perkins, Krisstina Gowin, Alissa Weber, Ruben A. Mesa, Jason Gotlib, Lixia Wang, Jack W. Singer, Moshe T...> ;Leukemia & Lymphoma. 2019 Mar 21
• 47 citations
  Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms.
  Raajit K. Rampal, John Mascarenhas, Heidi E. Kosiorek, Leah Price, Dmitriy Berenzon, Elizabeth O. Hexner, Camille N. Abboud, Marina Kremyanskaya, Rona Singer Weinberg,...> ;Blood Advances. 2018 Dec 26
• Treatment With JAK Inhibitors in Myelofibrosis Patients Nullifies the Prognostic Impact of Unfavorable Cytogenetics
  Vincent T. Ma, Philip S. Boonstra, Kamal Menghrajani, Cecelia Perkins, Krisstina Gowin, Ruben A. Mesa, Jason Gotlib, Moshe Talpaz> ;Clinical Lymphoma, Myeloma & Leukemia. 2018 May 1
• Choosing for whom to recommend allogeneic transplantation for acute myeloid leukemia in CR1: a continued, complicated conversation
  Kamal Menghrajani, Martin S. Tallman> ;Blood Advances. 2018 Jan 23
• 4 citations
  New therapeutic strategies for high-risk acute myeloid leukemia.
  Kamal Menghrajani, Martin S. Tallman> ;Current Opinion in Hematology. 2017 Dec 1
• Join now to see all

Lectures

• Loss of Plasmacytoid Dendritic Cell Differentiation Is Highly Predictive for Persistent Measurable Residual Disease and Poor Outcomes in Acute Myeloid Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018